tiprankstipranks
Trending News
More News >
Globestar Therapeutics Corporation (GSTC)
:GSTC
US Market

GlobeStar Therapeutics (GSTC) Financial Statements

Compare
16 Followers

GlobeStar Therapeutics Financial Overview

GlobeStar Therapeutics's market cap is currently $1.24K. The company's EPS TTM is $0; its P/E ratio is ―; GlobeStar Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Sep 22Sep 21Sep 20Sep 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 77.00$ 425.00
Gross Profit$ 0.00$ 0.00$ -2.41K$ -37.60K$ 271.00
Operating Income$ -1.86M$ -1.27M$ -9.09M$ -303.67K$ -315.87K
EBITDA$ 6.72K$ -1.26M$ -9.09M$ -302.34K$ -314.23K
Net Income$ -1.95M$ -1.64M$ -9.67M$ -779.79K$ -1.04M
Balance Sheet
Cash & Short-Term Investments$ 0.00$ 6.37K$ 5.96K$ 81.44K$ 100.46K
Total Assets$ 0.00$ 9.91K$ 5.96K$ 89.91K$ 142.18K
Total Debt$ 366.00K$ 20.00K$ 106.13K$ 155.08K$ 113.80K
Net Debt$ 366.00K$ 13.63K$ 100.17K$ 73.64K$ 13.34K
Total Liabilities$ 1.43M$ 1.20M$ 731.78K$ 749.13K$ 827.62K
Stockholders' Equity$ -1.43M$ -1.19M$ -725.82K$ -659.22K$ -685.43K
Cash Flow
Free Cash Flow$ -205.76K$ -327.00K$ -751.23K$ -241.52K$ -260.14K
Operating Cash Flow$ -205.76K$ -327.00K$ -751.23K$ -239.74K$ -260.14K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -1.78K$ 0.00
Financing Cash Flow$ 199.40K$ 327.40K$ 675.75K$ 222.50K$ 269.00K
Currency in USD

GlobeStar Therapeutics Earnings and Revenue History

GlobeStar Therapeutics Debt to Assets

GlobeStar Therapeutics Cash Flow

GlobeStar Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis